[On the action and use of the synthetic anticholinergic glycopyrrolate (Nodapton) in diseases of the stomach and intestinal tract].
D000818:Animals; D002986:Clinical Trials as Topic; D005745:Gastric Acidity Determination; D005756:Gastritis / Q000188:drug therapy; D005759:Gastroenteritis / Q000188:drug therapy; D006024:Glycopyrrolate / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007410:Intestinal Diseases / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use*; D013272:Stomach Diseases / Q000188:drug therapy*; D013276:Stomach Ulcer / Q000188:drug therapy
D010276:Parasympatholytics; D006024:Glycopyrrolate
Uber die Wirkung und Anwendung des synthetischen Anticholinergikums Glycopyrrolat (Nodapton) bei Erkrankungen des Magen-Darm-Traktes.